Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stellar Biotechnologies Exceeds Aquaculture Capacity Goals

Published: Tuesday, July 23, 2013
Last Updated: Tuesday, July 23, 2013
Bookmark and Share
Facility expansion and cultivation innovations ensure supply leadership.

Stellar Biotechnologies, Inc. has announced that the Company exceeded its 2012 plan to increase key stages of its aquaculture capacity to prepare for future demand for Keyhole Limpet Hemocyanin (KLH).

For the year ending 2012, Stellar exceeded its aquaculture hatchery goal by nearly 30%, the combined result of expanded facilities and new methods related to the cultivation of the Giant Keyhole Limpet (Megathura crenulata).

The Giant Keyhole Limpet is a scarce sea mollusk and the sole source for KLH, a vitally important, immune-stimulating protein.

Following expansion of Stellar’s physical plant in 2011, the Company developed new and proprietary methods for cultivating limpets that ensures unprecedented survival rates of this important natural resource.

Stellar’s hatchery innovations and controlled conditions have optimized the Company’s production; increasing yields and setting the stage for long-term KLH capacity while reducing environmental impact.

The net result, given sufficient funding, is to accelerate Stellar’s projected KLH production capacity to as much as 5 kilograms per year within the next four years, to 20 kilograms per year a few years later.

“This positions Stellar as the only company that will be capable of supplying GMP grade KLH that can meet the anticipated long-term demand within the pharmaceutical industry,” said Frank Oakes, President and CEO. “This is a testament to our customer focus and operational excellence.”

“Exceeding aquaculture capacity ahead of schedule means we will be prepared to ensure scalable supplies of the highest quality KLH for our pharmaceutical partners,” said Brandon Lincicum, Stellar Executive Director of Aquaculture.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stellar Appoints Tessie Che, Ph.D. to Board of Directors
Dr. Che is currently Chair of the Board of Directors of Amaran Biotechnology.
Thursday, September 26, 2013
Stellar Biotechnologies Presents at Annual 2013 NSF Conference
Poster titled “Megathura crenulata Post Larval Culture - Bottleneck for a Valuable Medical Resources” was presented by Brandon Lincicum.
Friday, July 05, 2013
Stellar’s Exclusive License Agreement on Bayer Innovations/Stellar KLH Technology
The license includes a carve-out by BIG for use of the technology in its non-Hodgkin lymphoma vaccine which is currently under development.
Thursday, December 09, 2010
Stellar Biotechnologies Announces Achievement of Milestone in Cooperation with Bayer Innovation
The Company announces collaboration with Bayer Innovation GmbH for the development of a personalized Non-Hodgkin's-Lymphoma vaccine.
Tuesday, September 21, 2010
Stellar Biotechnologies Welcomes Malcolm Gefter, Ph.D. to Corporate and Scientific Advisory Boards
The addition of Malcolm Gefter brings great senior-level directive talent and experience to Company’s corporate board.
Tuesday, July 13, 2010
Scientific News
Oxygen Can Impair Cancer Immunotherapy
Researchers have identified a mechanism within the lungs where anticancer immune resposnse is inhibited.
Symmetry is Key to Collagen
Researchers describe how symmetry may be the key to growing collagen fibres outside the body.
Breakthrough in GPCR Understanding
Integral Molecular announces breakthrough in understanding the functionality of GPCRs, the largest class of drug targets in human disease.
Designing Ultrasound Tools with Lego-Like Proteins
Study outlines how ultrasound technology can be used for imaging in conjuction with protein engineering.
Enzyme that Triggers Cell Demise in ALS Identified
Scientists from Harvard have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis (ALS).
Molecular Alarm Clock Wakes Resting Ovules
Study of fruit flies yields discovery of a molecular "alarm clock" that activates resting ovules.
Catching Proteins in the Act
Scientists can now observe light activated processes in proteins through the use of free-electron x-ray lasers.
Proteins Preserve Vital Genetic Data
Research has shown how two key proteins bring about the oragnization of chromosomes and our genome.
Signaling Molecule Regulates Release of the Hunger Hormone Ghrelin
Researchers at UT Southwestern have identified that the blocking release of the hormone ghrelin may mediate low blood sugar effect in children taking beta blockers.
Telomere Replenishment in Real Time
Researchers have visualised the process of telomere attachment to chromosomes through single-molecule imaging.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!